Trends in Antibiotic Use in U.S. Hospitals during the COVID-19 Pandemic
05 June 2021
We described antibiotic use among inpatients with coronavirus disease 2019 (COVID-19). Most COVID-19 inpatients received antibiotic therapy. We also described hospital-wide antibiotic use during 2020 compared with 2019, stratified by hospital COVID-19 burden. While total antibiotic use decreased between years, certain antibiotic use increased with higher COVID-19 burden.
Further reading: Open Forum Infectious Diseases
Author(s): Ashley N Rose, MPH, James Baggs, PhD, Hannah Wolford, MSPH, Melinda M Neuhauser, PharmD, MPH, Arjun Srinivasan, MD, Adi V Gundlapalli, MD, PhD, Sujan Reddy, MD, MSc, Lyudmyla Kompaniyets, PhD, MS, Audrey F Pennington, PhD, MPH, Cheri Grigg, DVM, MPH, Sarah Kabbani, MD, MSc
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
